New Treatment for Retinal Vein Occlusion

From October 1, 2015, a new treatment for Retinal Vein Occlusion will be available on the PBS (Pharmaceutical Benefits Scheme). Aflibercept is a type of injection in the eye to treat swelling of the macula part of the retina (CRVO) which can cause blindness or vision loss if left untreated. This joins another new eye injection Ranibizumab for both BRVO and CRVO which has recently been available on the PBS since July 1 2015. Please discuss with our retina specialists who will be able to determine if these treatments are appropriate for you.